Contineum Therapeutics reported total assets of $250.37M and total liabilities of $10.71M for the quarter ended Jun 2026, up 36.9% year over year. This balance sheet covers 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 1.48M | 1.72M | ||||||||||||
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash & EquivalentsCash & Equiv. | 15.53M | 16.26M | 77.23M | 40.89M | 21.94M | 22.47M | 20.78M | 42.63M | 75.60M | 20.16M | 14.71M | |||
| Prepaid Assets | 2.52M | 1.80M | 1.67M | 1.23M | 1.63M | 1.42M | 1.35M | 2.52M | 5.02M | 6.64M | 6.03M | |||
| Current Assets | 127.71M | 119.71M | 220.32M | 215.14M | 206.39M | 192.13M | 176.84M | 184.93M | 267.92M | 252.96M | 242.58M | |||
| Non-Current Assets | ||||||||||||||
| Property, Plant & Equipment (Net) | 0.68M | 0.76M | 0.80M | 0.89M | 0.99M | 0.89M | 0.86M | 0.88M | 0.83M | 1.06M | 0.93M | |||
| Other Non-Current Assets | 1.28M | 2.62M | 0.00M | 0.00M | 0.00M | 0.00M | 0.19M | 0.27M | 0.26M | 0.31M | 0.36M | |||
| Non-Current Assets | 2.68M | 3.85M | 1.03M | 0.89M | 6.46M | 6.13M | 6.05M | 5.92M | 8.72M | 8.38M | 7.79M | |||
| Assets | 130.39M | 123.56M | 221.35M | 216.03M | 212.85M | 198.26M | 182.89M | 190.85M | 276.64M | 261.35M | 250.37M | |||
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payables | 0.64M | 0.57M | 0.73M | 1.40M | 1.81M | 3.65M | 2.00M | 0.79M | 1.02M | 1.50M | 0.51M | |||
| Payables | 0.64M | 0.57M | 0.73M | 1.40M | 1.81M | 3.65M | 2.00M | 0.79M | 1.02M | 1.50M | 0.51M | |||
| Accumulated Expenses | 4.38M | 5.19M | 2.52M | 3.80M | 6.71M | 3.85M | 3.75M | 4.10M | 6.39M | 2.86M | 3.63M | |||
| Other Accumulated Expenses | 1.55M | 1.89M | 0.97M | 1.34M | 3.15M | 2.48M | 1.69M | 1.17M | ||||||
| Current Leases | 0.46M | 0.47M | 0.48M | 0.61M | 1.45M | 1.46M | 1.47M | 1.48M | 2.34M | 2.30M | 2.39M | |||
| Total Current Liabilities | 5.48M | 6.23M | 3.74M | 5.81M | 9.97M | 8.95M | 7.21M | 6.36M | 9.74M | 6.66M | 6.53M | |||
| Non-Current Liabilities | ||||||||||||||
| Preferred Stock Liabilities | 192.62M | 192.62M | ||||||||||||
| Operating Leases | 0.11M | 0.11M | 0.11M | 6.26M | 4.55M | 4.28M | 4.02M | 8.25M | 6.95M | 6.57M | ||||
| Other Non-Current Liabilities | 0.11M | 0.23M | ||||||||||||
| Total Non-Current Liabilities | 5.59M | 6.34M | 3.85M | 5.81M | 14.78M | |||||||||
| Total Liabilities | 97.46M | 55.43M | 61.15M | 5.70M | 6.57M | 3.85M | 5.81M | 14.78M | 13.50M | 11.50M | 10.38M | 15.65M | 11.31M | 10.71M |
| Shareholder's Equity | ||||||||||||||
| Common Equity | -97.46M | -55.43M | -61.15M | -67.94M | -75.63M | 217.50M | 210.23M | 198.07M | 184.77M | 171.39M | 180.47M | 260.99M | 250.04M | 239.66M |
| Liabilities and Shareholders Equity | 130.39M | 123.56M | 221.35M | 216.03M | 212.85M | 198.26M | 182.89M | 190.85M | 276.64M | 261.35M | 250.37M | |||
| Retained Earnings | -75.14M | -83.60M | 310.17M | 312.48M | 315.37M | 317.96M | 320.65M | 342.40M | 438.07M | 442.09M | 447.19M | |||
| Treasury Shares | 15.91M | 15.91M |